colorectal polyps
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients receiving anticoagulants with colorectal polyps under 20mm diameter Performance status 0 or 1 WBC over3000/mm3 and under12000/mm3 Hb over9.0g/dL Plt over100000/mm3 AST,ALT under100IU T.Bil under2.0mg/dL Ccr less than1.77mg/dL and Ccr over15ml/min PT-INR under3 (less than70 years old) PT-INR under2.6(over70 years old)
Exclusion criteria
Exclusion criteria: Contraindicated cases for taking revaroxaban Patients with artifical heart valve Patients with vasucular atrial fibrillation Liver chirrhosis patients with type B or C in child-pugh classfication Patients taking azole antifungal drug,the HIV-protease inhihibitors or drugs including cobicistat Patinens contracting acute infective endocarditis Women who are or may be pregnant Patients taking aspirin or Thienopyridine Dialysis patients Patients with past history of gastrointestinal bleeding or intracranial hemorrhage
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| analysis of delayed bleeding after colorectal polypectomy and EMR for 4 weeks | — |
Countries
Japan
Contacts
Asahi General Hospital Dept. of Gastroenterology